PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France. Electronic address: sladoire@cgfl.fr.\', \'Clinical Research Center (CRC), Centre Georges François Leclerc, Dijon, France.\', \'Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France.\', \'Methodology and Biostatistics Unit, Centre Georges François Leclerc, Dijon, France.\', \'Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; Bioinformatic Core Facility Georges-François Leclerc Cancer Center, Dijon, France.\', \'Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.\', \'Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Department of Pathology and Tumor Biology, Centre Georges François Leclerc, Dijon, France.\', \'University of Burgundy-Franche Comté, France; Department of Oncologic Surgery, Centre Georges François Leclerc, Dijon, France.\', \'Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France; Research Platform in Biological Oncology, Georges François Leclerc Cancer Center, Dijon, France; Centre de Recherche INSERM LNC-UMR1231, Dijon, France; University of Burgundy-Franche Comté, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0959-8049(22)00018-110.1016/j.ejca.2022.01.005
?:doi
?:hasPublicationType
?:journal
  • European journal of cancer (Oxford, England : 1990)
is ?:pmid of
?:pmid
?:pmid
  • 35189537
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35189537>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35189537>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all